This job has expired

You will need to login before you can apply for a job.

Sr. Accountant

Employer
Vaxcyte, Inc.
Location
San Carlos, California
Start date
Aug 6, 2022

View more

Discipline
Administration, Accounting
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay
You need to sign in or create an account to save a job.

Job Details

Company Profile:

Vaxcyte, Inc. (Nasdaq: PCVX) is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent some of the most common and deadly infectious diseases worldwide. Our exclusively licensed cell-free protein synthesis platform and our proprietary know how enable us to design and produce optimized protein carriers and antigens, the critical building blocks of vaccines, in ways that we believe conventional vaccine technologies cannot. Our lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease. Our pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.
 
Vaxcyte, headquartered in San Carlos, CA, went public in June 2020 and currently has a team of approximately 100 employees and anticipates continued, significant growth. On January 6, 2022, Vaxcyte announced that the U.S. Food and Drug Administration (FDA) had cleared the Investigational New Drug (IND) application for VAX-24, its lead vaccine candidate. The Company initiated the VAX-24 Phase 1/2 clinical proof-of-concept study in adults in the first quarter of 2022 and expects to announce Phase 2 topline immunogenicity, safety, and tolerability results by the end of the year. VAX-24 was designed to prevent IPD, which can be most serious for infants, young children, older adults and those with immune deficiencies or certain chronic health conditions. Given the global impact of pneumococcal disease remains significant, the public health community continues to advocate for vaccines that can offer broader protection to prevent IPD. Vaxcyte’s PCV franchise, consisting of VAX-24 and VAX-XP, is designed specifically to address this need and has the potential to deliver the broadest protection for this very serious disease.
 
Summary:

Reporting to the Associate Director of Accounting, the Senior Accountant will lead various month-end close activities, including journal entries, reconciliations, financial statement fluctuation analyses and audit support.

The ideal candidate is one who has an aptitude for learning, especially in uncharted territory, customer-centric and accustomed to a fast-paced environment. In addition, we are looking for a candidate who is flexible and has a passion for innovation and improvement in processes. A successful candidate is one who has great attention to details and strong oral and written communication skills.
Essential Functions:
    • Prepare journal entries for month-end, quarter-end, and year-end GL close.
    • Perform account analyses and reconciliations.
    • Prepare Open PO accruals and assist with clinical trial accruals.
    • Collaborate with the Clinical Department and other cross functional departments to ensure accuracy and completeness of operating expenses.
    • Prepare fluctuation analyses.
    • Assist with the implementation and maintain and adhere to internal controls under SOX 401(b) and policies and procedures.
    • Prepare schedules for quarterly reviews and annual audits.
    • Prepare schedules for income tax, property tax and research & development credits.
    • Assist with preparation of various internal and external financial statements.
    • Assist with implementation of various financial systems and special projects.

Requirements:
    • Degree in Accounting or Finance.
    • 5+ years of accounting experience.
    • Accounting knowledge with accrual-based accounting.
    • Previous experience with an ERP system – NetSuite a plus.
    • Industry experience in biotech a plus.
    • Accounting experience in a publicly traded company required.
    • Strong oral and written communication skills with proven ability to effectively communicate to employees at all levels and to outside vendors.
    • Strong Excel skills.
    • Ability to manage multiple tasks under strict deadlines with meticulous attention to detail.
    • Positive work ethic and organizational skills with a high attention to detail and unquestionable integrity and personal ethics.
    • A collaborative team player, able to partner with internal and external contacts at all levels.
    • Ability to work independently and as a part of a team, shift focus, and adapt to changing priorities.
    • Exceptional focus on customer service.
    • All Vaxcyte employees require vaccination against COVID-19.

Reports to: Associate Director of Accounting

Location: San Carlos, CA

Compensation: 
The compensation package will be competitive and includes comprehensive benefits and an equity component.


Company

Vaxcyte, Inc. (Nasdaq: PCVX) is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent some of the most common and deadly infectious diseases worldwide. Our exclusively licensed cell-free protein synthesis platform and our proprietary know how enable us to design and produce optimized protein carriers and antigens, the critical building blocks of vaccines, in ways that we believe conventional vaccine technologies cannot. Our lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease. Our pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.

Find Us
Website
Phone
(650) 837-0111
Location
353 Hatch Drive
Foster City, CA 94404
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert